UPDATE 1-FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose

Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, raising questions around its chemistry, manufacturing and controls (CMC).